nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.08.2018 | Original Article

Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus

verfasst von: Y. Ding, Q. Ge, H. Qu, Z. Feng, J. Long, Q. Wei, Q. Zhou, R. Wu, L. Yao, H. Deng

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the association between serum periostin and the presence of diabetic retinopathy (DR).

Methods

Serum periostin was detected in 114 healthy subjects, 122 patients with type 2 diabetes mellitus (T2DM) and 159 patients with DR and compared among groups. Clinical data and other laboratory measurements such as glycated hemoglobin (HbA1c), lipid profiles, serum creatinine (Cr) and high-sensitivity CRP (hsCRP) were also collected and compared among groups. For subgroup analysis, patients with DR were divided into a non-proliferated diabetic retinopathy (NPDR) group and a proliferated diabetic retinopathy (PDR) group. Multivariate analysis was performed using logistic regression models.

Results

The serum periostin level was significantly higher in patients with diabetic retinopathy compared with healthy subjects and patients with T2DM (both P < 0.001, respectively). Also, the periostin level was significantly higher in the PDR group compared to the NPDR group (P = 0.044). Multivariate logistic regression revealed that serum periostin was independently associated with the presence of DR in patients with T2DM (P < 0.001). The receiver operating characteristic (ROC) curves for DR development using serum periostin showed that the area under the receiver operating characteristic curves (AUC) was 0.838 (P < 0.001).

Conclusions

The current study demonstrated that serum periostin is significantly associated with the presence of DR in patients with T2DM and is an independent risk factor of DR.

Wan TT, Li XF, Sun YM, Li YB, Su Y (2015) Recent advances in understanding the biochemical and molecular mechanism of Diabetic retinopathy. Biomed Pharmacother 74:145–147CrossRefPubMed

Geng P, Ding Y, Qiu L, Lu Y (2015) Serum mannose-binding lectin is a strong biomarker of diabetic retinopathy in Chinese patients with diabetes. Diabetes Care 38:868–875CrossRefPubMed

Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183CrossRefPubMed

Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–564CrossRefPubMedPubMedCentral

Liu Z, Fu C, Wang W, Xu B (2010) Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross sectional hospital based survey in urban China. Health Qual Life Outcomes 8:62CrossRefPubMedPubMedCentral

Das A, Stroud S, Mehta A, Rangasamy S (2015) New treatments for diabetic retinopathy. Diabetes Obes Metab 17:219–230CrossRefPubMed

Simó R, Hernández C (2015) Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence. Prog Retin Eye Res 48:160–180CrossRefPubMed

Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS (2014) Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int 2014:801269CrossRefPubMedPubMedCentral

Dong N, Shi H, Xu B, Cai Y (2015) Increased plasma S100A12 levels are associated with diabetic retinopathy and prognostic biomarkers of macrovascular events in type 2 diabetic patients. Invest Ophthalmol Vis Sci 56:4177–4185CrossRefPubMed

10.

Takada M, Ban Y, Yamamoto G et al (2010) Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun 399:221–226CrossRefPubMed

11.

Idolazzi L, Ridolo E, Fassio A, Gatti D, Montagni M, Caminati M, Martignago I, Incorvaia C, Senna G (2017) Periostin: the bone and beyond. Eur J Intern Med 38:12–16CrossRefPubMed

12.

Yoshida S, Ishikawa K, Asato R et al (2011) Increased expression of periostin in vitreous and membranes obtained from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 52:5670–5678CrossRefPubMed

13.

Lu Y, Liu X, Jiao Y et al (2014) Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. J Clin Invest 124:3501–3513CrossRefPubMedPubMedCentral

14.

Luo Y, Qu H, Wang H, Wei H, Wu J, Duan Y, Liu D, Deng H (2016) Plasma periostin levels are increased in Chinese subjects with obesity and type 2 diabetes and are positively correlated with glucose and lipid parameters. Mediat Inflamm 2016:6423637

15.

Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O (2015) Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. PLoS One 10:e0124055CrossRefPubMedPubMedCentral

16.

Guan J, Liu WQ, Xing MQ, Shi Y, Tan XY, Jiang CQ, Dai HY (2015) Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan. BMC Cardiovasc Disord 15:90CrossRefPubMedPubMedCentral

17.

Cheruvu VK, Odhiambo LA, Mowls DS, Zullo MD, Gudina AT (2016) Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J Chron Obstruct Pulmon Dis 11:2211–2219CrossRefPubMedPubMedCentral

18.

Ryan H, Trosclair A, Gfroerer J (2012) Adult current smoking: differences in definitions and prevalence estimates–NHIS and NSDUH, 2008. J Environ Public Health 2012:918368CrossRefPubMedPubMedCentral

19.

Li Z, Xu K, Wu Z, Sun Y, Song Z, Jin D, Liu P (2014) Alcohol consumption and visual impairment in a rural Northern Chinese population. Ophthalmic Epidemiol 21(6):384–390CrossRefPubMed

20.

Contié S, Voorzanger-Rousselot N, Litvin J, Clézardin P, Garnero P (2011) Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases. Int J Cancer 128(2):352–360CrossRefPubMed

21.

Hong L, Sun H, Lv X, Yang D, Zhang J, Shi Y (2010) Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 37(5):2285–2293CrossRefPubMed

22.

Thomson NC, Chaudhuri R, Spears M, Haughney J, McSharry C (2015) Serum periostin in smokers and never smokers with asthma. Respir Med 109(6):708–715CrossRefPubMed

23.

Fingleton J, Braithwaite I, Travers J et al (2016) Serum periostin in obstructive airways disease. Eur Respir J 47(5):1383–1391CrossRefPubMedPubMedCentral

24.

Rousseau JC, Sornay-Rendu E, Bertholon C, Chapurlat R, Garnero P (2014) Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J Clin Endocrinol Metab 99(7):2533–2539CrossRefPubMed

25.

Walsh JS, Gossiel F, Scott JR, Paggiosi MA, Eastell R (2017) Effect of age and gender on serum periostin: relationship to cortical measures, bone turnover and hormones. Bone 99:8–13CrossRefPubMed

26.

Zhu JZ, Zhu HT, Dai YN (2016) Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study. Endocrine 51(1):91–100CrossRefPubMed

27.

Yang Z, Zhang H, Niu Y et al (2016) Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects. Sci Rep 6:37886CrossRefPubMedPubMedCentral

28.

Qian H, Ripps H (2011) Neurovascular interaction and the pathophysiology of diabetic retinopathy. Exp Diabetes Res 2011:693426CrossRefPubMedPubMedCentral

29.

Li C, Miao X, Li F, Wang S, Liu Q, Wang Y, Sun J (2017) Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy. Oxid Med Cell Longev 2017:9702820PubMedPubMedCentral

30.

Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ, Fahy JV (2010) Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA 107:14170–14175CrossRefPubMed

31.

Yuyama N, Davies DE, Akaiwa M et al (2002) Analysis of novel disease-related genes in bronchial asthma. Cytokine 19:287–296CrossRefPubMed

32.

Snider P, Hinton RB, Moreno-Rodriguez RA (2008) Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res 102:752–760CrossRefPubMedPubMedCentral

33.

Mael-Ainin M, Abed A, Conway SJ (2014) Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol 25:1724–1736CrossRefPubMedPubMedCentral

34.

Prakoura N, Kavvadas P, Kormann R, Dussaule JC, Chadjichristos CE, Chatziantoniou C (2017) NFκB-induced periostin activates integrin-β3 signaling to promote renal injury in GN. J Am Soc Nephrol 28:1475–1490CrossRefPubMed

35.

Yamashita O, Yoshimura K, Nagasawa A, Ueda K, Morikage N, Ikeda Y, Hamano K (2013) Periostin links mechanical strain to inflammation in abdominal aortic aneurysm. PLoS One 8:e79753CrossRefPubMedPubMedCentral

36.

Liu AY, Zheng H, Ouyang G (2014) Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol 37:150–156CrossRefPubMed

37.

Schwanekamp JA, Lorts A, Vagnozzi RJ, Vanhoutte D, Molkentin JD (2016) Deletion of periostin protects against atherosclerosis in mice by altering inflammation and extracellular matrix remodeling. Arterioscler Thromb Vasc Biol 36:60–68PubMedCrossRef

38.

Hakuno D, Kimura N, Yoshioka M, Mukai M, Kimura T, Okada Y, Yozu R, Shukunami C, Hiraki Y, Kudo A, Ogawa S, Fukuda K (2010) Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Investig 120:2292–2306CrossRefPubMed

39.

Nguyen TT, Alibrahim E, Islam FM (2009) Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 32:1704–1709CrossRefPubMedPubMedCentral

40.

Cunha-Vaz J, Ribeiro L, Lobo C (2014) Phenotypes and biomarkers of diabetic retinopathy. Prog Retin Eye Res 41:90–111CrossRefPubMed

41.

Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef

42.

Januszewski AS, Karschimkus C, Davis KE, O’Neal D, Ward G, Jenkins AJ (2012) Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Res Clin Pract 95:e17–e19CrossRefPubMed

43.

McVicar CM, Ward M, Colhoun LM, Guduric-Fuchs J, Bierhaus A, Fleming T, Schlotterer A, Kolibabka M, Hammes HP, Chen M, Stitt AW (2015) Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice. Diabetologia 58:1129–1137CrossRefPubMedPubMedCentral

44.

Sacks FM, Hermans MP, Fioretto P et al (2014) Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation 129:999–1008CrossRefPubMed

45.

Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O’Neal DN, Januszewski AS (2015) Biomarkers in diabetic retinopathy. Rev Diabet Stud 12(1–2):159–195CrossRefPubMedPubMedCentral

46.

Dirani M, Xie J, Fenwick E, Benarous R, Rees G, Wong TY, Lamoureux EL (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52(7):4416–4421CrossRefPubMed

47.

Keen H, Lee ET, Russell D, Miki E, Bennett PH, Lu M et al (2001) The appearance of retinopathy and progression to proliferative retinopathy: the WHO Multinational study of vascular disease in diabetes. Diabetologia 44(Suppl 2):S22–S30CrossRefPubMed

48.

van Leiden HA, Dekker JM, Moll AC et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: The Hoorn Study. Diabetes Care 25:1320–1325CrossRefPubMed

49.

Tolonen N, Hietala K, Forsblom C et al (2013) Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: The Finn Diane Study. J Intern Med 274:469–479CrossRefPubMed

50.

Henricsson M, Nystrom L, Blohme G et al (2003) The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based diabetes incidence study in Sweden (DISS). Diabetes Care 26:349–354CrossRefPubMed

51.

Zhang L, Krzentowski G, Albert A, Lefebvre PJ (2001) Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275–1279CrossRefPubMed

52.

Zhou Y, Zhang Y, Shi K, Wang C (2017) Body mass index and risk of diabetic retinopathy: a meta-analysis and systematic review. Medicine (Baltimore) 96(22):e6754CrossRef

53.

Cai X, Han X, Zhang S, Luo Y, Chen Y, Ji L (2014) Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS One 9:e91174CrossRefPubMedPubMedCentral

54.

UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317(7160):703–713CrossRefPubMedCentral

55.

Sarangi R, Padhi S, Mohapatra S, Swain S, Padhy RK, Mandal MK, Patro SK, Kumar S (2012) Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males. Diabetes Metab Syndr 6:9–14CrossRefPubMed

56.

Fronczyk A, Molęda P, Safranow K, Piechota W, Majkowska L (2014) Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control. Inflammation 37:349–357CrossRefPubMed

57.

Klein BE, Knudtson MD, Tsai MY, Klein R (2009) The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol 127:1175–1182CrossRefPubMedPubMedCentral

Titel: Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus
verfasst von: Y. Ding
Q. Ge
H. Qu
Z. Feng
J. Long
Q. Wei
Q. Zhou
R. Wu
L. Yao
H. Deng
Publikationsdatum: 01.08.2018
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 8/2018
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-017-0820-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2018

Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer

Endocrinological aspects of HIV infection

Comparison of the effects of the l-dopa and insulin tolerance tests on cortisol secretion

Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time

Body composition and circulating estradiol are the main bone density predictors in healthy young and middle-aged men

Denosumab or oral bisphosphonates in primary osteoporosis: a “real-life” study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin